DUBLIN–(BUSINESS WIRE)–The “Reporter
Gene Assay Market by Reagents & Assay Kits (Luciferase, Green
Fluorescent Protein, â-glucuronidase, â-galactosidase), Application
(Gene Regulation, Protein Interaction, Cell Signalling Pathways), End
Users, Region – Global Forecast to 2024” report has been added
to ResearchAndMarkets.com’s offering.
The reporter gene assays market is expected to reach USD 2.6 billion by
2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%.
Growth in this market is driven by increasing funding for cell-based
research, the growing applications of gene expression, and a rising
preference for cell-based assays. However, the high cost of cell biology
research is expected to restrain the growth of this market to a certain
extent during the forecast period.
The market is highly competitive, with numerous players competing for a
larger market share. The prominent players in the global reporter gene
assays market include Merck KGaA (Germany), Thermo Fisher Scientific
(US), Promega Corporation (US), Abcam plc (UK), PerkinElmer (US),
Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad
Laboratories (US), Geno Technology (US), GeneCopoeia, Inc. (US),
InvivoGen (France), PromoCell (Germany), Biotium (US), and Canvax
(Spain).
By end user, the academic and research institutes segment is
projected to have the largest market share during the forecast period
(2019-2024)
On the basis of end user, the reporter gene assays market is segmented
into academic and research institutes, pharmaceutical and biotechnology
companies, hospital and diagnostic laboratories, and contract research
organizations. The academic and research institutes segment is expected
to account for the largest share in 2019. The large share of this
end-user segment can be attributed to the increasing government
initiatives towards drug discovery and life science R&D activities.
The cell signaling segment is expected to grow at the
highest CAGR during the forecast period
On the basis of application, the reporter gene assays market is
segmented into gene regulation, protein interaction, cell signaling
pathways, and promotor structural & functional analysis. The cell
signaling applications segment is expected to witness the highest CAGR
owing to its importance in several cellular functionalities such as cell
differentiation, cell fate determination, and cell growth, and advanced
applications of cell signaling in life science sectors such as
biotechnology, molecular biology, and microbiology.
APAC is projected to witness the highest growth during the
forecast period
North America is expected to account for the largest share of the global
reporter gene assays market in 2019. On the other hand, the APAC region
is expected to witness the highest CAGR during the forecast period,
owing to the large population in China and India, rising geriatric
population, and increasing incidence of chronic diseases. Also, owing to
the high growth opportunities in the APAC region, many manufacturers are
expanding their global manufacturing bases to this region. With their
low-cost manufacturing advantage, China and India are regarded as the
most profitable manufacturing and R&D locations by manufacturers.
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2
Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2
Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6
Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1
Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2
Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2
Break Down of Primary Sources
2.2 Market Size Estimation
2.3
Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5
Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Reporter Gene Assays:
Market Overview
4.2 Reporter Gene Assays Market: Geographic
Overview (2018)
4.3 Regional Mix: Reporter Gene Assays Market
(2019-2024)
4.4 Reporter Gene Assays Market: Developed vs
Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market
Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Funding for
Cell-Based Research
5.2.1.2 Growing Applications of Gene Expression
5.2.1.3
Rising Preference for Cell-Based Assays
5.2.2 Restraint
5.2.2.1
High Cost of Cell Biology Research
5.2.3 Opportunities
5.2.3.1
Emerging Countries
5.2.3.2 Increasing Demand for Personalized
Medicine
6 Reporter Gene Assays Market, By Product
6.1
Introduction
6.2 Assay Kits
6.2.1 Luciferase Assay Kits
6.2.1.1
Luciferase Assays Dominate the Assay Kits Market
6.2.2 Fluorescent
Protein-Related Assay Kits
6.2.2.1 Fluorescent Reporter Proteins
are Useful in Studying Cellular Events
6.2.3 Secreted Embryonic
Alkaline Phosphatase Assay Kits
6.2.3.1 Advantages of Seap Assays
Over Luciferase and Cat Counterparts Have Supported the Growth of This
Segment
6.2.4 Chloramphenicol Acetyltransferase Assay Kits
6.2.4.1
A Cat Assay is A Standard Method for Assessing Promotor Expression in
Transfected Cell Lines
6.2.5 Beta-Galactosidase Assay Kits
6.2.5.1
Ease of Use and Rapidity of These Assays Have Contributed to Their
Overall Demand
6.2.6 Beta-Glucuronidase Assay Kits
6.2.6.1 Gus
Reporter Assays are Mainly Used for Plant Gene Expression Research
6.2.7
Other Assay Kits
6.3 Reagents
6.3.1 Increasing Demand for
High-Quality Reagents in Biosciences and Biotechnology has Driven
Reagent Use
7 Reporter Gene Assays Market, By Application
7.1
Introduction
7.2 Cell Signaling Pathways
7.2.1 Cell Signaling
Pathways is the Largest Application Segment of the Reporter Gene Assays:
Market
7.3 Promoter Structural and Functional Analysis
7.3.1
Reporter Gene Assays Allow for the Functional Identification and
Characterization of Promoter and Enhancer Elements
7.4 Gene
Regulation
7.4.1 Reporter Gene Assays Acts as Powerful Tools in
Analyzing Gene Regulations
7.5 Protein Interaction
7.5.1
Reporter Gene Assays are Used for the Identification and Quantitative
Analysis of Protein-Protein Interaction
8 Reporter Gene Assays Market, By End User
8.1
Introduction
8.2 Academic & Research Institutes
8.2.1
Academic & Research Institutes are the Largest End Users of the Reporter
Gene Assays: Market
8.3 Pharmaceutical & Biotechnology Companies
8.3.1
Increasing Number of R&D Activities to Drive the Market Growth for
Pharmaceutical & Biotechnology Companies
8.4 Contract Research
Organizations (CROS)
8.4.1 CROS to Provide Affordable Outlets for
Companies and Academia to Pursue New Medicines
8.5 Hospital &
Diagnostic Laboratories
8.5.1 High Prevalence of Chronic Diseases
to Drive the Market Growth Among Hospital & Diagnostic Laboratories
9 Reporter Gene Assays Market, By Region
9.1
Introduction
9.2 North America
9.2.1 US
9.2.1.1 US
Dominates the North American Reporter Gene Assays: Market
9.2.2
Canada
9.2.2.1 Canada to Witness the Highest Growth in the North
American Market Primarily Due to the Increasing Research Activities
9.3
Europe
9.3.1 Germany
9.3.1.1 Favorable Funding Scenario to
Support Market Growth in Germany
9.3.2 France
9.3.2.1
Increasing Government Investments in Proteomics & Genomics Research to
Drive Market Growth
9.3.3 UK
9.3.3.1 Surge in the Prevalence
of Cancer and Neurological Disorders is Driving the Adoption of Reporter
Gene Assays
9.3.4 Italy
9.3.4.1 Growing Proteomics and
Genomics Research to Drive the Growth of the Reporter Gene Assays:
Market in Italy
9.3.5 Spain
9.3.5.1 Increasing Private and
Public Funding for Cell-Based Research and the Presence of A Strong R&D
Infrastructure to Drive Market Growth
9.3.6 Rest of Europe
9.4
Asia Pacific
9.4.1 China
9.4.1.1 China to Register the Highest
Growth in the Global Reporter Gene Assays Market, Primarily Due to the
Large R&D Investments in the Country
9.4.2 Japan
9.4.2.1
Increasing Incidence of Chronic Diseases and Growing Geriatric
Population to Drive Market Growth
9.4.3 India
9.4.3.1
Expansion of Pharmaceutical Companies
9.4.4 Rest of Asia Pacific
9.5
Latin America
9.5.1 Increasing Number of Proteomics and Genomics
Research Activities to Support Market Growth in the Region
9.6
Middle East & Africa
9.6.1 Several Leading Global Players are
Focusing on Expanding Their Presence in the MEA Region
10 Competitive Landscape
10.1 Overview
10.2
Market Share Analysis
10.2.1 Market Share Analysis: Reporter Gene
Assays Market
10.3 Competitive Leadership Mapping
10.3.1
Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic
Differentiators
10.3.4 Emerging Companies
10.4 Competitive
Situation and Trends
10.4.1 Expansions
10.4.2 Acquisitions
11 Company Profiles
11.1 Merck KGaA
11.2
Thermo Fisher Scientific Inc.
11.3 Promega Corporation
11.4
Perkinelmer
11.5 Abcam PLC
11.6 Becton, Dickinson and Company
11.7
Bio-Rad Laboratories
11.8 Danaher Corporation
11.9 Biotium
11.10
Promocell
11.11 Invivogen
11.12 Geno Technology Inc.
11.13
Genecopoeia Inc.
For more information about this report visit https://www.researchandmarkets.com/research/2n5pdc/global_reporter?w=4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology